期刊文献+

IN SITU PCR AND IMMUNOHISTOCHEMICAL STUDIES ON p16 GENE IN PITUITARY ADENOMAS

IN SITU PCR AND IMMUNOHISTOCHEMICAL STUDIES ON p16 GENE IN PITUITARY ADENOMAS
下载PDF
导出
摘要 Objective: To examine the occurrence of p16 gene deletion and to analyze p16 expression on paraffin-embedded human pituitary adenoma specimens. Efforts were made to optimize the technical conditions forin situ PCR. Methods:In situ PCR techniques and inimuno-histochemistry were used. Results: Immunohistochemically, p16-positive tumor cells were observed in all cases with various proportions. The majority of the stromal cells and part of tumor cells was devoid of p16 immunostaining, but signal ofin situ PCR for p16 gene, exon 2, was displayed in these cells. Conclusion: The results implied that p16 gene might not be deleted in these pituitary adenomas. It also indicated thatin situ PCR, both direct and indirect methods, proved feasible and informative to the aim of DNA detection. It is critical to overcome non-specific amplification in directin situ PCR by means of higher annealing temperature, fewer cycle, lower magnesium concentration and stringent washing. A target DNA-deleted sample as the negative control is extremely necessary. For the indirect method, the way to improve the sensitivity is to loosen the conditions for amplification and washing, so that more amplification products are subject to hybridization, and signal detection is facilitated. Objective: To examine the occurrence of p16 gene deletion and to analyze p16 expression on paraffin-embedded human pituitary adenoma specimens. Efforts were made to optimize the technical conditions forin situ PCR. Methods:In situ PCR techniques and inimuno-histochemistry were used. Results: Immunohistochemically, p16-positive tumor cells were observed in all cases with various proportions. The majority of the stromal cells and part of tumor cells was devoid of p16 immunostaining, but signal ofin situ PCR for p16 gene, exon 2, was displayed in these cells. Conclusion: The results implied that p16 gene might not be deleted in these pituitary adenomas. It also indicated thatin situ PCR, both direct and indirect methods, proved feasible and informative to the aim of DNA detection. It is critical to overcome non-specific amplification in directin situ PCR by means of higher annealing temperature, fewer cycle, lower magnesium concentration and stringent washing. A target DNA-deleted sample as the negative control is extremely necessary. For the indirect method, the way to improve the sensitivity is to loosen the conditions for amplification and washing, so that more amplification products are subject to hybridization, and signal detection is facilitated.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2000年第1期10-15,共6页 中国癌症研究(英文版)
基金 a grant from Ministry of Public Health of China!(98-l-303)
关键词 In situ PCR IMMUNOHISTOCHEMISTRY p16 gene Pituitary adenoma In situ PCR Immunohistochemistry p16 gene Pituitary adenoma
  • 相关文献

参考文献30

  • 1易静,于德蓉,陈玉英,熊文浩,李骁雄,沈建康,汤雪明.P16 overexpression in pituitary adenomas studied by immunohistochemistry and in situ hybridization[J].Chinese Medical Journal,2000(2):66-70. 被引量:5
  • 2Kamb A,Gruis NA,Weaver-Feldhaus J,et at.A cellcycle regulator potentially involved in genesis of manytumor types. Science . 1994
  • 3Nobori T,Miura K,Wu DJ,et al.Deletion of the cyclin-dependent kinase 4 inhibitor gene in multiple human cancers. Nature . 1994
  • 4Calms P,Mao L,Merlo A,et at.Rates of pl6 (MTSL)mutation in primary tumors with 9p loss. Science . 1994
  • 5Marx J.A challenge to pl6 gene as a major tumorsuppressor. Science . 1994
  • 6Spruck III CH,Gonzalez-Zulueta M,Shibata A,et at.P16 gene in uncultured tumours. Nature . 1994
  • 7Kamb A,Liu Q,Harsbman K,et at.Response to: Ratesof pl6 (MTS l) mutation in Primary tumors with 9p loss. Science . 1994
  • 8Walker DG,Duan W,Popovic EA,et at.Homozygousdeletion of the multiple tumor suppressor gene 1 in theProgression of human astrocytoma. Cancer Research . 1995
  • 9Nuovo GJ.PCR in situ Hybridization, Protocols andApplications, 3rd ed. New York: Lippincott-Raven . 1997
  • 10Osuke W,Masaaki N,Hirotaka O,et at.In vivooccurrence of pl6 (MTSL) and p15 (MTS2) alterationspreferentially in non-small cell lung cancers. Cancer Research . 1995

二级参考文献10

  • 1Reed AL,Califano J,Cairns P,et al.High frequency of p16(CDK2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma[].Cancer Research.1996
  • 2Serrano M,Hannon GJ,Beach D.A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4[].Nature.1993
  • 3Woloschak M,Yu A,Post KD.Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation[].Molecular Carcinogenesis.1997
  • 4Okamoto A,Demetrick DJ,Spillare EA,et al.Mutations and altered expression of p16INK4A in human cancer[].Proceedings of the National Academy of Sciences of the United States of America.1994
  • 5Hall PA,Levison DA.Assessment of cell proliferation in histological material[].Journal of Clinical Pathology.1990
  • 6Spruck CH,Gonzalez-Zulueta M,Shibata A,et al.P16 gene in uncultured tumours[].Nature.1994
  • 7Asamoto M,Hori T,Baba-Toriyama H,et al.P16 gene overexpression in mouse bladder carcinomas[].Cancer Letters.1998
  • 8Shigemasa K,Hu C,West CM,et al.P16 overexpression: a potential early indicator of transformation in ovarian carcinoma[].Journal of the Society for Gynecologic Investigation.1997
  • 9Kamb A,Gruis NA,Weaver-Feldhaus J,et al.A cell cycle regulator potentially involved in genesis of many tumor types[].Science.1994
  • 10Platz A,Sevigny P,Norberg T,et al.Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases[].British Journal of Cancer.1996

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部